Corium Internation (CORI) Misses Q1 EPS by 4c

Go back to Corium Internation (CORI) Misses Q1 EPS by 4c

Corium International (CORI) PT Lowered to $8 at Jefferies

February 15, 2017 8:22 AM EST

Jefferies lowered its price target on Corium International (NASDAQ: CORI) to $8.00 (from $9.00) while maintaining a Buy rating.

Analyst David Steinberg commented, "CORI posted a slightly narrower than expected loss (-$10.4M vs -$11.2M JEF). Key pipeline product donepezil TD... More

Corium International (CORI) PT Lowered to $10 at Needham & Company on Revenue Volatility; Keeps 'Buy'

February 14, 2017 6:30 AM EST

Needham & Company analyst Serge Belanger reiterates Buy rating, but lowers price target on Corium International (NASDAQ: CORI) to $10 (from $12), expecting volatility in revenues, despite the company completing the second of three treatment periods in the ongoing pilot BE study for the Donepezil... More